 BEVERLY HILLS, Calif., June 16, 2021 PRNewswire -- GT Biopharma, Inc. GT Biopharma or the Company NASDAQ: GTBP, a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Companys proprietary natural killer NK cell engager TriKETM protein biologic technology platform, today announced that it will provide a corporate update at the upcoming Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 11:20 AM ET. 